Biomarin Pharmaceutical (BMRN) Gains from Equity Investments (2009 - 2011)
Biomarin Pharmaceutical (BMRN) recorded quarterly Gains from Equity Investments of $542000.0 in Q1 2011, down 31.91% on a QoQ basis from $796000.0 in Q4 2010, and down 21.56% year-over-year from $691000.0 in Q1 2010.
Biomarin Pharmaceutical (BMRN) Gains from Equity Investments (2009 - 2011) Analysis & Trends
Biomarin Pharmaceutical has disclosed Gains from Equity Investments across 3 years of filings, most recently posting $542000.0 for Q1 2011.
- Quarterly Gains from Equity Investments fell 21.56% year-over-year to $542000.0 in Q1 2011, while the trailing twelve-month figure through Mar 2011 was $2.8 million (changed N/A YoY) and the FY2010 annual result came in at $3.0 million, up 15.3% from the prior year.
- Gains from Equity Investments fell to $542000.0 in Q1 2011, from $796000.0 in the prior quarter.
- Over five years, Gains from Equity Investments peaked at $864000.0 in Q2 2010 and troughed at $542000.0 in Q1 2011.
- A 3-year average of $719142.9 and a median of $691000.0 in 2010 frame the typical range for Gains from Equity Investments.
- Annual changes were most pronounced in 2010 — Gains from Equity Investments fell 3.05% — and 2011, when it retreated 21.56%.
- Tracing BMRN's Gains from Equity Investments over 3 years: stood at $821000.0 in 2009, then decreased by 3.05% to $796000.0 in 2010, then tumbled by 31.91% to $542000.0 in 2011.
- Business Quant data shows BMRN's Gains from Equity Investments at $542000.0 in Q1 2011, $796000.0 in Q4 2010, and $640000.0 in Q3 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Biomarin Pharmaceutical | 10.52 Bn | 8.29 Bn | 571.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2011 | 542,000.00 |
| Mar 31, 2011 | 542,000.00 |
| Dec 31, 2010 | 796,000.00 |
| Dec 31, 2010 | 796,000.00 |
| Sep 30, 2010 | 640,000.00 |
| Sep 30, 2010 | 640,000.00 |
| Jun 30, 2010 | 864,000.00 |
| Jun 30, 2010 | 864,000.00 |
| Mar 31, 2010 | 691,000.00 |
| Mar 31, 2010 | 691,000.00 |
| Dec 31, 2009 | 821,000.00 |
| Dec 31, 2009 | 821,000.00 |
| Sep 30, 2009 | 680,000.00 |
| Sep 30, 2009 | 680,000.00 |